The Peptide Craze Ground Truths Adverse Event Reporting in Clinical Trials A pharmacovigilance datadriven approach to reveal high fatal adverse events following checkpoint immunotherapy PNAS The Irish National Adverse Event Study 2 (INAES 2): longitudinal trends in adverse event rates in the Irish healthcare system BMJ Quality & Safety Can Sermorelin Peptide Aid in Weight Loss? Lawrenceville GA In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas